492 Frequency and Co-occurrence of MAPK and PI3K Pathway Driver Mutations to Guide Single-agent and Combination Therapies: an Analysis of Next Generation Sequence Data From 2700 Patients
Bowden, E.T, Wyngaard, P, Khazanov, N.A, Eddy, S, Tomilo, M, Williams, P, Sadis, S, Rhodes, D.R
Published in European journal of cancer (1990) (01.11.2012)
Published in European journal of cancer (1990) (01.11.2012)
Get full text
Journal Article
P1.21-11 Immunotherapy Response Score (IRS) Predicts Pembrolizumab Clinical Benefit in Patients with NSCLC in TPS≥50
Suga, J., Thomas, S., Achacoso, N., Jiang, C., Chung, E., Solorzano-Pinto, A., Tse, P., Bulen, B.J., Khazanov, N.A., Lamb, L.E., Hovelson, D.H., Kwiatkowski, K., Johnson, D.B., Rhodes, D.R., Tomlins, S.A., Habel, L.A.
Published in Journal of thoracic oncology (01.11.2023)
Published in Journal of thoracic oncology (01.11.2023)
Get full text
Journal Article